HOME  | CONTACT  | PATIENT LOGIN  | CLINIC LOGIN  | FAQ
  • PATIENTS &
    HEALTHY VOLUNTEERS
  • INVESTIGATORS
  • CROS / SPONSORS
  • CAREERS
  • TRIAL ALERTS

TRIALS SEARCH
      
  • HEALTH NEWS

  • RSS FEEDS

  • ABOUT TRIALS

  • LINK TO US


View Clinical Trial (Medical Research Study)


Addressing Parental Smoking by Changing Pediatric Office Systems

Signup
Browse Studies

City:   Boston
State:   Massachusetts
Zip Code:   02114
Conditions:   Tobacco Use Disorder
Purpose:   RATIONALE: The Clinical Effort Against Secondhand Smoke (CEASE) program may be more effective than standard care in increasing the number of parents who stop smoking. PURPOSE: This randomized clinical trial is studying how well the CEASE program works compared with standard care in helping parents stop smoking.
Study Summary:   OBJECTIVES: - To compare the effectiveness of the Clinical Effort Against Secondhand Smoke (CEASE) intervention vs no intervention in increasing clinicians' delivery of evidence-based parental smoking cessation assistance in pediatric healthcare settings. - To compare the effectiveness of this intervention vs no intervention on parental smoking behaviors. - To test the level of systematic practice implementation of the intervention using existing validated measures in an Implementation Process Survey (IPS). - To evaluate, in an exploratory fashion, additional key implementation step measures mapped from the five A's (Ask, Advise, Assess, Assist, Arrange) to see how well they predict tobacco control service delivery in pediatric healthcare settings. - To use process results from the IPS (i.e., previously validated and exploratory measures) to improve the adoption, implementation, and maintenance of the intervention in this study. OUTLINE: This is a multicenter study. Participants are stratified according to practice. Participants are randomized to 1 of 2 intervention arms. - Arm I (Clinical Effort Against Secondhand Smoke [CEASE] intervention): The CEASE intervention incorporates a number of materials into the operations of the pediatric practice, including baseline questionnaires that screen for parental tobacco use and readiness to quit smoking, enroll in quitline counseling, or explore pharmacotherapy; a label that affixes to the child's problem list in the medical record, documenting parental smoking status and indicating the patient's secondhand exposure, thus encouraging continuity of cessation support in cross-coverage situations; and decision support for clinicians that prompts delivery of exposure-reduction counseling and distribution of motivational-messaging handouts (i.e., halflets) to parents for education, skills training, and psychosocial support. Parental messaging elements include strategies or methods for quitting, collaborative goal setting, identifying personal barriers to quitting, and focused strategies for reducing secondhand-smoke exposure of the patient. Additional intervention materials include a HIPAA-compliant form for enrolling the smoker in counseling through the telephone quitline; pre-printed, practice-embossed prescription pads for prescribing over-the-counter nicotine-replacement therapy when desired by the smoker; pharmacotherapy posters in pediatric patient examination rooms to inform parental smokers and assist clinicians in discussing tobacco dependence treatment; and a simple implementation guide to support integrating the parent, clinician, and practice levels of the intervention. The CEASE intervention also incorporates telephone counseling after the pediatric healthcare visit to ensure that parents receive professional, ongoing smoking-cessation counseling. Parental smokers undergo an exit interview survey and follow-up telephone surveys at 3 months and 12 months for evaluation of content of tobacco control delivered during the visit; use of messaging materials, medications, and telephone counseling sessions; current smoking status; and rules about smoking in the home and car. If the parent has had a 7-day quit at the 12-month follow-up, the parent is also asked to provide a saliva sample for cotinine analysis to confirm nonsmoking status. - Arm II (control): Participants complete a questionnaire at baseline and an exit interview survey. They also complete telephone interviews at 3 month and 12 months. If the parent has had a 7-day quit at the 12-month follow-up, the parent is also asked to provide a saliva sample for cotinine analysis to confirm nonsmoking status. In both arms, participating practitioners and key office staff complete Implementation Process Surveys at baseline and at 6 weeks and 6 months.
Criteria:   DISEASE CHARACTERISTICS: - Parents or guardians meeting the following criteria: - Self-identified as smokers on the baseline survey - Must have a child who is seen by a pediatrician in a participating practice - Child must not have a medically emergent condition that requires transfer outside the practice for immediate medical intervention - Must be present at the child's healthcare visit - Pediatric practice meeting the following criteria: - Participates in the Pediatric Research in Office Settings (PROS) network - Practice manager and a majority of pediatricians are willing to implement a tobacco control strategy for parental smokers - Cares for at least 2,000 families - Located in a geographically distinct location to minimize contamination effects of the intervention - No practices at the same geographic location PATIENT CHARACTERISTICS: - Have a telephone at home (parent or guardian) - Able to speak English (parent or guardian) - Have a working fax machine (practice) PRIOR CONCURRENT THERAPY: - No prior enrollment in this study during a previous visit to the pediatric healthcare clinician (parent or guardian) - No prior participation in phase II focus groups or other pilot tobacco control studies (practice) - No active enrollment of patients onto other PROS trials (practice)
NCT ID:   NCT00664261
Primary Contact:   Study Chair
Jonathan Winickoff, MD, MPH
Massachusetts General Hospital

Backup Contact:   N/A
Location Contact:   Boston, Massachusetts 02114
United States

Clinical Trials Office - Massachusetts General Hospital
Phone: 877-726-5130

Site Status: Recruiting

Data Source:   ClinicalTrials.gov
Date Processed:   June 18, 2013
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


  • NEARBY STUDIES

Within 25 Miles

Tai Chi and Aerobic Exercise for Fibromyalgia - Boston MA

Gingivitis - Cambridge MA

Gum Disease - Cambridge MA

Postherpetic Neuralgia (Post-shingles pain) - Roslindale MA

Crohn's Disease - Quincy MA

Cataracts - Quincy MA

Chronic Low Back Pain - Watertown MA

Healthy Volunteers (Weighing less than 175 lbs) - Boston MA

Healthy Volunteers (Weighing more than 175 lbs) - Boston MA

Chronic Lower Back Pain - Brockton MA

Diabetic Neuropathy - Brockton MA

Fibromyalgia - Brockton MA

Constipation with Chronic Lower Back Pain - Brockton MA

High Cholesterol - Brockton MA

Gout with Heart Conditions - Brockton MA

Irritable Bowel Syndrome - Brockton MA

Low Back Pain and Constipation - Brockton MA

Anti-Depressant Induced Sexual Dysfunction - Brighton MA

Anti-Depressant Induced Sexual Dysfunction - South Weymouth MA

Obsessive Compulsive Disorder (OCD) - Boston MA

Post Herpatic Neuralgia - Brockton MA

Chronic Lower Back Pain and Constipation - Brockton MA

Uncontrolled Angina (Adult Stem Cell Research) - Boston MA

Rosacea - Brockton MA

Osteoarthritis - Brockton MA

COPD (Emphysema and Chronic Bronchitis) - Waltham MA

Healthy Volunteers (Ages 65-80) - Boston MA

Phenylketonuria (PKU) - Boston MA

Within 50 Miles

Alzheimer's Disease - East Providence RI

Restless Legs Syndrome (RLS) - Warwick RI

Asthma (Ages 18-65) - Warwick RI

Low Back Pain and Constipation - Fall River MA

Low Back Pain and Constipation - Warwick RI

Arthritis - Fall River MA

Postherpetic Neuralgia (Post-shingles pain) - New Bedford MA

Osteoarthritis - New Bedford MA

Obsessive Compulsive Disorder (OCD) - Providence RI

COPD (Emphysema and Chronic Bronchitis) - Fall River MA

Arthritis - Ayer MA

Heart Attack or Stroke - Johnston RI

Pediatric Migraines (Ages 12-17) - Worcester MA

COPD (Emphysema and Chronic Bronchitis) - North Dartmouth MA

Within 100 Miles

Arthritis - New London CT

Arthritis - Biddeford ME

Anti-Depressant Induced Sexual Dysfunction - Norwich CT

Painful Intercourse - New London CT

 
Clinical Connections Home | Investigators | CROs / Sponsors | Clinical Trials Notification | Search Clinical Trials | About Clinical Trials | Links | Terms And Conditions | Sitemap | Suggestions / Feedback
© 1998-2013 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.